French RR - Search Results

1

Fc gamma receptor IIb on target B cells promotes rituximab internalization and reduces clinical efficacy.

Lim SH, Vaughan AT, Ashton-Key M, Williams EL, Dixon SV, Chan HT, Beers SA, French RR, Cox KL, Davies AJ, Potter KN, Mockridge CI, Oscier DG, Johnson PW, Cragg MS, Glennie MJ. Lim SH, et al. Among authors: french rr. Blood. 2011 Sep 1;118(9):2530-40. doi: 10.1182/blood-2011-01-330357. Epub 2011 Jul 18. Blood. 2011. PMID: 21768293 Free article.

2

Complement-mediated lysis by anti-CD20 mAb correlates with segregation into lipid rafts.

Cragg MS, Morgan SM, Chan HT, Morgan BP, Filatov AV, Johnson PW, French RR, Glennie MJ. Cragg MS, et al. Among authors: french rr. Blood. 2003 Feb 1;101(3):1045-52. doi: 10.1182/blood-2002-06-1761. Epub 2002 Sep 19. Blood. 2003. PMID: 12393541 Free article.

3

A new anti-idiotype antibody capable of binding rituximab on the surface of lymphoma cells.

Cragg MS, Bayne MB, Tutt AL, French RR, Beers S, Glennie MJ, Illidge TM. Cragg MS, et al. Among authors: french rr. Blood. 2004 Oct 15;104(8):2540-2. doi: 10.1182/blood-2004-05-1733. Epub 2004 Jun 22. Blood. 2004. PMID: 15213098 Free article.

4

Eradication of lymphoma by CD8 T cells following anti-CD40 monoclonal antibody therapy is critically dependent on CD27 costimulation.

French RR, Taraban VY, Crowther GR, Rowley TF, Gray JC, Johnson PW, Tutt AL, Al-Shamkhani A, Glennie MJ. French RR, et al. Blood. 2007 Jun 1;109(11):4810-5. doi: 10.1182/blood-2006-11-057216. Epub 2007 Feb 20. Blood. 2007. PMID: 17311995 Free article.

5

Mechanisms of killing by anti-CD20 monoclonal antibodies.

Glennie MJ, French RR, Cragg MS, Taylor RP. Glennie MJ, et al. Among authors: french rr. Mol Immunol. 2007 Sep;44(16):3823-37. doi: 10.1016/j.molimm.2007.06.151. Mol Immunol. 2007. PMID: 17768100 Review.

6

Induction of cytosolic calcium flux by CD20 is dependent upon B Cell antigen receptor signaling.

Walshe CA, Beers SA, French RR, Chan CH, Johnson PW, Packham GK, Glennie MJ, Cragg MS. Walshe CA, et al. Among authors: french rr. J Biol Chem. 2008 Jun 20;283(25):16971-84. doi: 10.1074/jbc.M708459200. Epub 2008 Apr 21. J Biol Chem. 2008. PMID: 18426802 Free article.

7

Type II (tositumomab) anti-CD20 monoclonal antibody out performs type I (rituximab-like) reagents in B-cell depletion regardless of complement activation.

Beers SA, Chan CH, James S, French RR, Attfield KE, Brennan CM, Ahuja A, Shlomchik MJ, Cragg MS, Glennie MJ. Beers SA, et al. Among authors: french rr. Blood. 2008 Nov 15;112(10):4170-7. doi: 10.1182/blood-2008-04-149161. Epub 2008 Jun 26. Blood. 2008. PMID: 18583569 Free PMC article.

8

Anti-CD20 monoclonal antibodies: historical and future perspectives.

Lim SH, Beers SA, French RR, Johnson PW, Glennie MJ, Cragg MS. Lim SH, et al. Among authors: french rr. Haematologica. 2010 Jan;95(1):135-43. doi: 10.3324/haematol.2008.001628. Epub 2009 Sep 22. Haematologica. 2010. PMID: 19773256 Free PMC article. Review.

9

Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection.

Beers SA, French RR, Chan HT, Lim SH, Jarrett TC, Vidal RM, Wijayaweera SS, Dixon SV, Kim H, Cox KL, Kerr JP, Johnston DA, Johnson PW, Verbeek JS, Glennie MJ, Cragg MS. Beers SA, et al. Among authors: french rr. Blood. 2010 Jun 24;115(25):5191-201. doi: 10.1182/blood-2010-01-263533. Epub 2010 Mar 11. Blood. 2010. PMID: 20223920 Free article.

10

CD20 as a target for therapeutic type I and II monoclonal antibodies.

Beers SA, Chan CH, French RR, Cragg MS, Glennie MJ. Beers SA, et al. Among authors: french rr. Semin Hematol. 2010 Apr;47(2):107-14. doi: 10.1053/j.seminhematol.2010.01.001. Semin Hematol. 2010. PMID: 20350657 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

65 results

Search Page